Product Information

VERAPAMIL 40 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.1174 per EA under NDC 62135074390. Its NADAC has been published 138 times since Jan 3, 2024.

FDA first approved this application on Apr 5, 1988. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

VERAPAMIL 40 MG TABLET

VERAPAMIL HYDROCHLORIDE
$0.1174per EA

Strength

40 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135074390

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

VERAPAMIL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA071881

FDA Approved

4/5/1988

TE Code

AB

On Market Since

10/15/2015

Pharmacological Classes

Calcium Channel Antagonists
Calcium Channel Blocker
Cytochrome P450 3A Inhibitors
Cytochrome P450 3A4 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for VERAPAMIL 40 MG TABLET has been published 138 times since Jan 3, 2024, and over the history we have for it it has declined 12.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1174 per EA
All-time high$0.1381 (Apr 10, 2024)
All-time low$0.1060 (Jul 17, 2024)
52-week high$0.1330
52-week low$0.1174
Median price$0.1251
Average price$0.1244
Largest weekly change+24.7% (Aug 21, 2024)
Weeks tracked138
Tracking sinceJan 3, 2024

Price History

1W

-0.6%

1M

-0.6%

3M

-1.2%

6M

-5.4%

1Y

-10.0%

3Y

N/A

5Y

N/A

All

-12.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of VERAPAMIL 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL 40 MG TABLET, manufactured by Chartwell RX LLC, is $0.1174 per EA (NDC 62135074390), effective Aug 19, 2026.

How has the price of VERAPAMIL 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for VERAPAMIL 40 MG TABLET has declined 12.3%. It has been tracked across 138 weekly CMS publications since Jan 3, 2024.

What are the highest and lowest recorded NADAC prices for VERAPAMIL 40 MG TABLET?

Since Jan 3, 2024, the NADAC for VERAPAMIL 40 MG TABLET has ranged from a low of $0.1060 (Jul 17, 2024) to a high of $0.1381 (Apr 10, 2024), with a median of $0.1251 per EA.

Are there cheaper alternatives to VERAPAMIL 40 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as VERAPAMIL 40 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures VERAPAMIL 40 MG TABLET?

VERAPAMIL 40 MG TABLET (NDC 62135074390) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.